People · Operator
Named in public records as an officer, director or promoter · active 2015–2025 · Biotechnology, Other Energy
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| NeXtGen Biologics, INC | — | Biotechnology | Seed | $5.9M | $347K | 2025 |
| Graphenix Development, Inc. | — | Other Energy | Seed | $3.1M | $17.3M | 2015 |
Brian Lipke at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Brian Lipke on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jamie Grooms | 1 | 4 |
| Yoram Katz | 1 | 3 |
| Mark Gold | 1 | 3 |
| Jonelle Toothman | 1 | 2 |
| Elad Levy | 1 | 1 |
| Rick Wassel | 1 | 1 |
| Gerald Kluft | 1 | 1 |
| Dan Hamister | 1 | 1 |
| Mark Hamister | 1 | 1 |
| Robert Anstey | 1 | 1 |
| Henry Coke | 1 | 1 |
| Rami Katz | 1 | 1 |
| William McKenna | 1 | 1 |
| Richard Anstey | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.